Gennex Laboratories [GENNEX] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Gennex Laboratories Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Gennex Laboratories Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Gennex Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gennex Laboratories Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 14.37 -13.65 Gennex Laboratories Ltd.
Price-to-Book Ratio 1.19 -13.55 Gennex Laboratories Ltd.
Debt-to-Equity Ratio 39.79 -1.21 Gennex Laboratories Ltd.
PEG Ratio -7.90 -11.15 Gennex Laboratories Ltd.
EV/EBITDA 16.60 -22.27 Gennex Laboratories Ltd.
Profit Margin (TTM) 12.59% -53.22% Gennex Laboratories Ltd.
Operating Margin (TTM) 13.54% -700.71% Gennex Laboratories Ltd.
EBITDA Margin (TTM) 13.54% N/A N/A
Return on Equity 9.31% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 7.08% -102.08% Gennex Laboratories Ltd.
Free Cash Flow (TTM) $-197.44M $-3.71B Gennex Laboratories Ltd.
1-Year Return -15.32% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.68 87.98 Gennex Laboratories Ltd.
Enterprise Value $3.08B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 2.03 95.73 Gennex Laboratories Ltd.
Gross Profit Margin (TTM) 29.90% -59.53% Gennex Laboratories Ltd.
Revenue per Share (TTM) $6 $2 Gennex Laboratories Ltd.
Earnings per Share (Diluted) $0.73 $-8.25 Gennex Laboratories Ltd.
Beta (Stock Volatility) 0.60 0.19 Sun Pharma Advanced Research Company Ltd.

Gennex Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

GENNEX
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gennex Laboratories Ltd.-1.42%-5.86%9.27%3.17%-21.03%-24.98%
Sun Pharma Advanced Research Company Ltd.2.09%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gennex Laboratories Ltd.-15.32%75.15%88.92%58.41%864.75%897.46%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Gennex Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGENNEXSPARC
Market Information
Market Cap i₹2.50B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i401,7722,401,062
90 Day Avg. Volume i626,7922,083,443
Last Close₹11.08₹208.50
52 Week Range₹7.05 - ₹17.25₹108.00 - ₹248.75
% from 52W High-35.77%-16.18%
All-Time High₹29.00 (Sep 16, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-61.79%-76.17%
Growth Metrics
Quarterly Revenue Growth0.07%-0.43%
Quarterly Earnings Growth0.13%-0.43%
Financial Health
Profit Margin (TTM) i0.13%-0.53%
Operating Margin (TTM) i0.14%-7.01%
Return on Equity (TTM) i0.09%1.58%
Debt to Equity (MRQ) i39.79-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹8.78₹-10.63
Cash per Share (MRQ)₹1.98₹0.03
Operating Cash Flow (TTM) i₹-75,467,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹181.23M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Gennex Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGENNEX (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i14.37-13.65
Forward P/E iN/A2.60
PEG Ratio i-7.90-11.15
Price to Sales (TTM) i1.6887.98
Price to Book (MRQ) i1.19-13.55
Market Capitalization
Market Capitalization i₹2.50B₹46.75B
Enterprise Value i₹3.08B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i2.0395.73
Enterprise to EBITDA i16.60-22.27
Risk & Other Metrics
Beta i0.600.19
Book Value per Share (MRQ) i₹8.78₹-10.63

Financial Statements Comparison: Gennex Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENNEX (2025)SPARC (2025)
Revenue/Sales i1.38B717.66M
Cost of Goods Sold i982.23M1.10B
COGS % of Revenue i71.4%153.2%
Gross Profit i393.29M-381.94M
Gross Margin i28.6%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i147.25M-3.34B
Operating Margin i10.7%-465.5%
EBITDA i271.66M-3.23B
EBITDA Margin i19.7%-450.0%
Pre-Tax Income i215.47M-3.43B
Pre-Tax Income % of Revenue i15.7%-477.6%
Income Tax i32.75M-2.72M
Income Tax % of Revenue i2.4%-0.4%
Net Income (Profit) i181.23M-3.43B
Profit Margin i13.2%-477.3%

Balance Sheet & Liquidity Metrics

MetricGENNEX (2025)SPARC (2025)
Cash & Equivalents i545.89M19.64M
Total Current Assets i1.81B261.97M
Total Current Assets % of Revenue i131.7%36.5%
Total Current Liabilities i445.55M3.74B
Total Current Liabilities % of Revenue i32.4%521.5%
Long-Term Debt i168.93M1.07B
Long-Term Debt % of Revenue i12.3%149.0%
Total Shareholders Equity i1.95B-2.17B
Retained Earnings i562.59M-23.22B
Retained Earnings % of Revenue i40.9%-3,235.0%
Property, Plant & Equipment i88.69M178.02M

Cash Flow Statement Comparison

MetricGENNEX (2025)SPARC (2025)
Operating Cash Flow i-75.47M-3.48B
Operating Cash Flow % of Revenue i-5.5%-485.5%
Capital Expenditures i-87.47M-97.45M
Free Cash Flow i-197.44M-3.71B
FCF Margin i-14.4%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENNEXSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i242.95M324.52M
Float Shares i156.62M91.32M
% Held by Insiders i33.66%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i66.34%24.48%

Dividend Analysis & Yield Comparison: Gennex Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricGENNEXSPARC
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A